A retrospective case series of eight patients with epidermal growth factor receptor inhibitor–induced cutaneous toxicities managed with dupilumab

Research output: Contribution to journalArticlepeer-review

Original languageEnglish (US)
Pages (from-to)17-22
Number of pages6
JournalJAAD Case Reports
Volume54
DOIs
StatePublished - Dec 2024
Externally publishedYes

Keywords

  • acneiform eruption
  • cancer care
  • cutaneous toxicity
  • dermatitis
  • dupilumab
  • eczematous dermatitis
  • epidermal growth factor inhibitor
  • erosive pustular dermatosis
  • oncodermatologist
  • oncodermatology
  • pruritus
  • targeted therapy
  • toxicity

ASJC Scopus subject areas

  • Dermatology

Cite this